6-Bromo-1H-pyrrolo[3,2-b]pyridine

Catalog No.: 
ACSMBY023
CAS No.: 
944937-53-5
Molecular Formula: 
C7H5BrN2
Molecular Weight: 
197.04
6-Bromo-1H-pyrrolo[3,2-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$83.00In stockInquiry
100g97%$321.00In stockInquiry
500g97%$1605.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-1H-pyrrolo[3,2-b]pyridine
IUPAC Name6-bromo-1H-pyrrolo[3,2-b]pyridine
MDL No.MFCD09266227
Molecular FormulaC7H5BrN2
Molecular Weight197.04
SMILESBrC1=CN=C2C(=C1)[NH]C=C2
InChI KeyOJFFFCVPCVATIV-UHFFFAOYSA-N
SynonymMFCD09266227 | SCHEMBL10535 | 6-BROMO-4-AZAINDOLE | SY018872 | BBL102049 | FS-3080 | Z1198219527 | STL555848 | AC-9429 | AKOS006331621 | EN300-192189 | FT-0653827 | 6-bromanyl-1H-pyrrolo[3,2-b]pyridine | OJFFFCVPCVATIV-UHFFFAOYSA-N | A844985 | CS-W008287
CAS No.944937-53-5
PubChem CID24229256

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSMBY023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDPUY540 route compound structure diagram
    ACDPUY54090902-84-4In Stock
  4. Then
  5. ACSMBY023 route product structure diagram
    ACSMBY023944937-53-5In Stock
Inquiry

2. ACSMBY023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSMBY023 route product structure diagram
    ACSMBY023944937-53-5In Stock
Inquiry

3. ACSMBY023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSMBY023 route product structure diagram
    ACSMBY023944937-53-5In Stock
Inquiry

Comments (0)